Dr. Steve Antoine discusses the STRONG-HF trial with co-host, Dr. Liz Wang.

0:00-2:37: Introduction

2:38-7:54: STRONG-HF trial overview

7:55-11:44: Overall thoughts

11:45-13:45: Baseline therapies

13:46-19:59: Discussion of titration and follow up in the trial

20:00-21:22: Ejection fraction considerations

21:23-23:22: Final thoughts

23:23-23:58: Closing



Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400(10367):1938-1952. doi:10.1016/S0140-6736(22)02076-1


Pitt B, Pfeffer MA, Assmann SF, et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014;370(15):1383-1392. doi:10.1056/NEJMoa1313731

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: